Don’t Miss the Enanta Pharmaceuticals Virtual Conference on October 19th – October 21st

Don’t Miss Enanta Pharmaceuticals Virtual Conference

Enanta Pharmaceuticals (ENTA) – a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced that new preclinical data for EDP-235 – its lead oral protease inhibitor, which is specifically designed for the treatment of COVID-19, will be presented at the International Society for Influenza and Other Respiratory Virus Diseases (ISIRV)-World Health Organization Virtual Conference (WHO): COVID-19, Influenza and RSV: Surveillance-Informed Prevention and Treatment.

To read more information about the ISIRV-WHO Virtual Conference 2021, please click here

The conference is being held virtually on October 19 – October 21, 2021.

Leave a Reply